Cargando…

Large-Scale Analysis of Determinants, Stability, and Heritability of High-Density Lipoprotein Cholesterol Efflux Capacity

OBJECTIVE—: Cholesterol efflux capacity (CEC) has emerged as a biomarker of coronary artery disease risk beyond plasma high-density lipoprotein (HDL) cholesterol (HDL-C) level. However, the determinants of CEC are incompletely characterized. We undertook a large-scale family-based population study t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koekemoer, Andrea L., Codd, Veryan, Masca, Nicholas G.D., Nelson, Christopher P., Musameh, Muntaser D., Kaess, Bernhard M., Hengstenberg, Christian, Rader, Daniel J., Samani, Nilesh J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2017
Materias:	Clinical and Population Studies
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627541/ https://www.ncbi.nlm.nih.gov/pubmed/28860221 http://dx.doi.org/10.1161/ATVBAHA.117.309201

Ejemplares similares

Moderate Renal Impairment Does Not Impact the Ability of CSL112 (Apolipoprotein A‐I [Human]) to Enhance Cholesterol Efflux Capacity
por: Gille, Andreas, et al.
Publicado: (2018)

Cholesterol Mass Efflux Capacity, Incident Cardiovascular Disease, and Progression of Carotid Plaque: The Multi-Ethnic Study of Atherosclerosis
por: Shea, Steven, et al.
Publicado: (2019)

Impact of Endothelial Lipase on Cholesterol Efflux Capacity of Serum and High-density Lipoprotein
por: Schilcher, Irene, et al.
Publicado: (2017)

CSL112 (Apolipoprotein A-I [Human]) Enhances Cholesterol Efflux Similarly in Healthy Individuals and Stable Atherosclerotic Disease Patients
por: Gille, Andreas, et al.
Publicado: (2018)

Effects of Antirheumatic Treatment on Cell Cholesterol Efflux and Loading Capacity of Serum Lipoproteins in Spondylarthropathies
por: Hokstad, Ingrid, et al.
Publicado: (2022)

Cholesterol efflux capacity is associated with lipoprotein size and vascular health in mild to moderate psoriasis
por: Berg, Alexander R., et al.
Publicado: (2023)

Causal Inference for Genetically Determined Levels of High-Density Lipoprotein Cholesterol and Risk of Infectious Disease
por: Trinder, Mark, et al.
Publicado: (2020)

Is High-Density Lipoprotein Cholesterol Causally Related to Kidney Function?: Evidence From Genetic Epidemiological Studies
por: Coassin, Stefan, et al.
Publicado: (2016)

The Association Between Reduction in Inflammation and Changes in Lipoprotein Levels and HDL Cholesterol Efflux Capacity in Rheumatoid Arthritis
por: Liao, Katherine P., et al.
Publicado: (2015)

High Density Lipoprotein Cholesterol Efflux Capacity and Atherosclerosis in Cardiovascular Disease: Pathophysiological Aspects and Pharmacological Perspectives
por: Adorni, Maria Pia, et al.
Publicado: (2021)

High-Density Lipoprotein Cholesterol Efflux Capacity as a Novel Prognostic Surrogate for Coronary Artery Disease
por: Hisauchi, Itaru, et al.
Publicado: (2021)

Moderate‐ and High‐Intensity Exercise Improves Lipoprotein Profile and Cholesterol Efflux Capacity in Healthy Young Men
por: Stanton, Kelly M., et al.
Publicado: (2022)

Leukocyte Telomere Length in Young Adults Born Preterm: Support for Accelerated Biological Ageing
por: Smeets, Carolina C. J., et al.
Publicado: (2015)

Large-Scale Analysis of the Association between Air Pollutants and Leucocyte Telomere Length in the UK Biobank
por: Bountziouka, Vasiliki, et al.
Publicado: (2023)

Prolonged bedrest reduces plasma high-density lipoprotein levels linked to markedly suppressed cholesterol efflux capacity
por: Trakaki, Athina, et al.
Publicado: (2020)

High-density lipoprotein cholesterol efflux capacity in patients with obstructive sleep apnea and its relation with disease severity
por: Fadaei, Reza, et al.
Publicado: (2022)

Robust passive and active efflux of cellular cholesterol to a designer functional mimic of high density lipoprotein
por: Luthi, Andrea J., et al.
Publicado: (2015)

Variants at the APOE/C1/C2/C4 Locus Modulate Cholesterol Efflux Capacity Independently of High‐Density Lipoprotein Cholesterol
por: Low‐Kam, Cécile, et al.
Publicado: (2018)

Uremia alters HDL composition and cholesterol efflux capacity
por: Holzer, Michael, et al.
Publicado: (2012)

High-density lipoprotein cholesterol efflux capacity is inversely associated with cardiovascular risk: a systematic review and meta-analysis
por: Qiu, Chengfeng, et al.
Publicado: (2017)

Low cholesterol efflux capacity and abnormal lipoprotein particles in youth with type 1 diabetes: a case control study
por: Gourgari, Evgenia, et al.
Publicado: (2018)

High-Density Lipoprotein Cholesterol Efflux Capacity as a Surrogate Marker for Major Cardiac Adverse Events in Japanese Patients
por: Komatsu, Tomohiro, et al.
Publicado: (2021)

Cholesterol efflux capacity of high‐density lipoprotein was not associated with cognitive decline and brain structures in older people with diabetes mellitus
por: Wu, Yuanyuan, et al.
Publicado: (2022)

Effects of size at birth, childhood growth patterns and growth hormone treatment on leukocyte telomere length
por: Smeets, Carolina C. J., et al.
Publicado: (2017)

Coronary Artery Disease–Associated LIPA Coding Variant rs1051338 Reduces Lysosomal Acid Lipase Levels and Activity in Lysosomes
por: Morris, Gavin E., et al.
Publicado: (2017)

Lipid-Based Nutrient Supplementation Increases High-Density Lipoprotein (HDL) Cholesterol Efflux Capacity and Is Associated with Changes in the HDL Glycoproteome in Children
por: Hong, Brian V., et al.
Publicado: (2021)

CETP (Cholesteryl Ester Transfer Protein) Inhibition With Anacetrapib Decreases Production of Lipoprotein(a) in Mildly Hypercholesterolemic Subjects
por: Thomas, Tiffany, et al.
Publicado: (2017)

High-Density Lipoprotein-Mediated Cholesterol Efflux Capacity Is Improved by Treatment With Antiretroviral Therapy in Acute Human Immunodeficiency Virus Infection
por: Lo, Janet, et al.
Publicado: (2014)

Development and validation of novel automatable assay for cholesterol efflux capacity
por: Mutsuda, Yume, et al.
Publicado: (2023)

Impaired Cholesterol Efflux Capacity of High-Density Lipoprotein Isolated From Interstitial Fluid in Type 2 Diabetes Mellitus—Brief Report
por: Apro, Johanna, et al.
Publicado: (2016)

Effects of Cardiac Rehabilitation on High-Density Lipoprotein-mediated Cholesterol Efflux Capacity and Paraoxonase-1 Activity in Patients with Acute Coronary Syndrome
por: Furuyama, Fumiaki, et al.
Publicado: (2018)

High-density lipoprotein cholesterol efflux capacity and incidence of coronary artery disease and cardiovascular mortality: a systematic review and meta-analysis
por: Cheng, Wenke, et al.
Publicado: (2022)

Correlations between the NMR Lipoprotein Profile, APOE Genotype, and Cholesterol Efflux Capacity of Fasting Plasma from Cognitively Healthy Elderly Adults
por: de Rojas, Itziar, et al.
Publicado: (2023)

Nascent HDL (High-Density Lipoprotein) Discs Carry Cholesterol to HDL Spheres: Effects of HDL Particle Remodeling on Cholesterol Efflux
por: Navdaev, Alexei V., et al.
Publicado: (2020)

Cholesterol efflux promoting function of high-density lipoproteins in calcific aortic valve stenosis
por: Kocyigit, Duygu, et al.
Publicado: (2021)

Genetic Loci Governing Androgenic Capacity in Perennial Ryegrass (Lolium perenne L.)
por: Begheyn, Rachel F., et al.
Publicado: (2018)

The negative effect of ANGPTL8 on HDL-mediated cholesterol efflux capacity
por: Luo, Mengdie, et al.
Publicado: (2018)

Lower than average HDL cholesterol efflux capacity in Lithuanian population
por: Kutkiene, Sandra, et al.
Publicado: (2019)

HDL cholesterol efflux capacity and lipid profile in patients with systemic sclerosis
por: Ferraz-Amaro, Iván, et al.
Publicado: (2021)

Effect of Anacetrapib on Cholesterol Efflux Capacity: A Substudy of the DEFINE Trial
por: Metzinger, Mark P., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1hc3v3rkqnfe40o9893vig8ujj